ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41301752

Shaping Precision Medicine: The Journey of Sequencing Technologies Across Human Solid Tumors.

Li W and 8 others. Biomedicines, 2025. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Shaping Precision Medicine: The Journey of Sequencing Technologies Across Human Solid Tumors. Papers, record 41301752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301752

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Shaping Precision Medicine: The Journey of Sequencing Technologies Across Human Solid Tumors.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-11-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li WWanwen
2Xiong CChanyu
3Chu CChenhttps://orcid.org/0000-0001-8084-0867
4Zhang YYun
5Wang ZZihao
6Wan ZZunmin
7Tang PPeng
8Zhu SShikaihttps://orcid.org/0000-0002-4805-8493
9Zhou YYuhttps://orcid.org/0000-0003-1216-9893

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZYGX2021J034National University Basic fundingPubMed
81970825National Natural Science Foundation of ChinaPubMed
22JCQN0028Department of Science and Technology of Sichuan ProvincePubMed
2024NSFSC0744Department of Science and Technology of Sichuan ProvincePubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References163

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,565,978Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors.JCO Precis Oncol2024https://conductscience.org/library/papers/39565978PubMed
235,800,097circFL-seq, A Full-length circRNA Sequencing Method.Bio Protoc2022https://conductscience.org/library/papers/35800097PubMed
320,010,852Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces.Lab Invest2010https://conductscience.org/library/papers/20010852PubMed
436,823,172Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas.Nat Commun2023https://conductscience.org/library/papers/36823172PubMed
59,823,339
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Cancer Res1998https://conductscience.org/library/papers/9823339PubMed
631,056,702
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Ann Oncol2019https://conductscience.org/library/papers/31056702PubMed
740,068,680Engineering mtDNA deletions by reconstituting end joining in human mitochondria.Cell2025https://conductscience.org/library/papers/40068680PubMed
829,567,706Personalized vaccines for cancer immunotherapy.Science2018https://conductscience.org/library/papers/29567706PubMed
939,367,090Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result.Sci Rep2024https://conductscience.org/library/papers/39367090PubMed
1039,227,743Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment.Nat Genet2024https://conductscience.org/library/papers/39227743PubMed

1 to 10 of 163

See all 163 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42,367,411The Present and Future Applications of Modern Technologies as Useful Tools in the Management of Cancer: A Narrative Review.Cureus2026https://conductscience.org/library/papers/42367411PubMed
41,899,608The Evolving Role for Repeat Molecular Testing in Metastatic Colorectal Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/41899608PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301752

GET https://conductscience.org/api/papers/v1/41301752/references?page=2

API referenceFor AI assistants